CD34+ cell subpopulations detected by 8-color flow cytometry in bone marrow and in peripheral blood stem cell collections: Application for MRD detection in leukemia patients

International Journal of Hematology

Volumn 90, Issue 3, 2009, Pages 292-302

  Björklund, Elisabet ^a   Gruber, Astrid ^a   Mazur, Joanna ^b   Mårtensson, Anna ^a,c   Hansson, Mona ^a   Porwit, Anna ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b INSTITUTE OF MOTHER AND CHILD   (Poland)

^c Box 23114 ^*  (Sweden)

Author keywords

Acute myeloid leukemia; CD34+ cells; Flow cytometry; Hematopoietic stem cell transplantation; Minimal residual disease

Indexed keywords

MONOCLONAL ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BONE MARROW BIOPSY; CD34 SELECTION; CELL SUBPOPULATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; LEUKEMIA CELL; MALE; MINIMAL RESIDUAL DISEASE; PERIPHERAL BLOOD STEM CELL; POLYCHROMATIC FLOW CYTOMETRY; PRESCHOOL CHILD; SCHOOL CHILD;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD34; BONE MARROW CELLS; CHILD; CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOPHENOTYPING; INFANT; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; NEOPLASM, RESIDUAL; REFERENCE VALUES;

EID: 76449094616     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-009-0389-z     Document Type: Article

References (45)

1. JG Bender KL Unverzagt DE Walker W Lee DE Van Epps DH Smith, et al. 1991 Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry Blood 77 2591 2596 1:STN:280:DyaK3M3lsFKktw%3D%3D 1710512
2. GE Tjonnfjord R Steen SA Evensen E Thorsby T Egeland 1994 Characterization of CD34+ peripheral blood cells from healthy adults mobilized by recombinant human granulocyte colony-stimulating factor Blood 84 2795 2801 1:STN:280:DyaK2M%2FgtlSjsA%3D%3D 7522643
3. T Inaba C Shimazaki T Hirata E Ashihara K Okawa N Oku, et al. 1994 Phenotypic differences of CD34-positive stem cells harvested from peripheral blood and bone marrow obtained before and after peripheral blood stem cell collection Bone Marrow Transplant 13 527 532 1:STN:280:DyaK2czjt1Slsw%3D%3D 7519935
4. G D'Arena N Cascavilla P Musto M Greco L Di Mauro AM Carella, et al. 1996 Flow cytometric characterization of CD34+ hematopoietic progenitor cells in mobilized peripheral blood and bone marrow of cancer patients Haematologica 81 216 223 8767526
5. L Perey R Peters S Pampallona P Schneider N Gross S Leyvraz 1998 Extensive phenotypic analysis of CD34 subsets in successive collections of mobilized peripheral blood progenitors Br J Haematol 103 618 629 10.1046/j.1365-2141.1998.01062.x 1:CAS:528:DyaK1MXhslKitw%3D%3D 9858209 (Pubitemid 28545294)
6. F de Boer AM Drager MJ Van Haperen E van der Wall F Kessler PC Huijgens, et al. 2000 The phenotypic profile of CD34-positive peripheral blood stem cells in different mobilization regimens Br J Haematol 111 1138 1144 10.1046/j.1365-2141.2000.02438.x 11167753 (Pubitemid 32104930)
7. G Basso F Lanza A Orfao S Moretti G Castoldi 2001 Clinical and biological significance of CD34 expression in acute leukemia J Biol Regul Homeost Agents 15 68 78 1:CAS:528:DC%2BD3MXovFSgt7c%3D 11388747
8. QL Hao J Zhu MA Price KJ Payne LW Barsky GM Crooks 2001 Identification of a novel, human multilymphoid progenitor in cord blood Blood 97 3683 3690 10.1182/blood.V97.12.3683 1:CAS:528:DC%2BD3MXksVOqsrs%3D 11389003
9. G Gaipa E Coustan-Smith E Todisco O Maglia A Biondi D Campana 2002 Characterization of CD34(+), CD13(+), CD33(-) cells, a rare subset of immature human hematopoietic cells Haematologica 87 347 356 11940478
10. P Menendez JA Perez-Simon MV Mateos MD Caballero M Gonzalez JF San Miguel, et al. 2002 Influence of the different CD34+ and CD34- subsets infused on clinical outcome after non-myeloblative allogeneic peripheral blood transplantation from human leukocyte antigen-identical sibling donors Br J Haematol 119 135 143 10.1046/j.1365-2141.2002.03794.x 12358918 (Pubitemid 35176513)
11. G D'Arena L Savino G Nunziata N Cascavilla R Matera G Pistolese, et al. 2002 Immunophenotypic profile of AC133-positive cells in bone marrow, mobilized peripheral blood and umbilical cord blood Leuk Lymphoma 43 869 873 10.1080/10428190290017015 12153177 (Pubitemid 34428676)
12. N Feller MC Jansen-van der Weide MA van der Pol GAH Westra GJ Ossenkoppele GJ Schuurhuis 2005 Purging of peripheral blood stem cell transplants in AML: a predictive model based on minimal residual disease burden Exp Hematol 33 120 130 10.1016/j.exphem.2004.10.007 15661405 (Pubitemid 40127651)
13. S Matarraz A Lopez S Barrena C Fernandez E Jensen J Flores, et al. 2008 The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34(+) hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursors Leukemia 22 1175 1183 10.1038/leu.2008.49 1:CAS:528:DC%2BD1cXntVCjtrw%3D 18337765 (Pubitemid 351833785)
14. SC De Rosa JM Brenchley M Roederer 2003 Beyond six colors: a new era in flow cytometry Nat Med 9 112 117 10.1038/nm0103-112 12514723 (Pubitemid 36098271)
15. U Petrausch D Haley W Miller K Floyd WJ Urba E Walker 2006 Polychromatic flow cytometry: a rapid method for the reduction and analysis of complex multiparameter data Cytometry A 69 1162 1173 17089357
16. A Macedo A Orfao J Ciudad M Gonzalez B Vidriales MC Lopez-Berges, et al. 1995 Phenotypic analysis of CD34 subpopulations in normal human bone marrow and its application for the detection of minimal residual disease Leukemia 9 1896 1901 1:STN:280:DyaK28%2FntFWnsA%3D%3D 7475281
17. P Lucio A Parreira MW van den Beemd EG van Lochem ER van Wering E Baars, et al. 1999 Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL Leukemia 13 419 427 10.1038/sj/leu/2401279 1:STN:280:DyaK1M7osVGgtQ%3D%3D 10086733
18. A Porwit-MacDonald E Bjorklund P Lucio EG van Lochem J Mazur A Parreira, et al. 2000 BIOMED-1 concerted action report: flow cytometric characterization of CD7+ cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL) Leukemia 14 816 825 10.1038/sj.leu.2401741 1:STN:280:DC%2BD3c3mtVKnug%3D%3D 10803512
19. P Lucio G Gaipa EG van Lochem ER van Wering A Porwit-MacDonald T Faria, et al. 2001 BIOMED-I concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings. BIOMED-1 concerted action investigation of minimal residual disease in acute leukemia: international standardization and clinical evaluation Leukemia 15 1185 1192 10.1038/sj.leu.2402150 1:CAS:528:DC%2BD3MXms1Ort7o%3D 11480560 (Pubitemid 32776442)
20. W Kern S Danhauser-Riedl R Ratei S Schnittger C Schoch HJ Kolb, et al. 2003 Detection of minimal residual disease in unselected patients with acute myeloid leukemia using multiparameter flow cytometry for definition of leukemia-associated immunophenotypes and determination of their frequencies in normal bone marrow Haematologica 88 646 653 12801840
21. JF San Miguel MB Vidriales C Lopez-Berges J Diaz-Mediavilla N Gutierrez C Canizo, et al. 2001 Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification Blood 98 1746 1751 10.1182/blood.V98.6.1746 1:CAS:528:DC%2BD3MXntFWgsbs%3D 11535507
22. A Reichle G Rothe S Krause M Zaiss H Ullrich G Schmitz, et al. 1999 Transplant characteristics: minimal residual disease and impaired megakaryocytic colony growth as sensitive parameters for predicting relapse in acute myeloid leukemia Leukemia 13 1227 1234 10.1038/sj/leu/2401481 1:STN:280: DyaK1Mznsl2lsg%3D%3D 10450751
23. T Miyazaki I Matsuda M Oguri H Amaya M Kiyosaki A Hamada, et al. 2001 Flow cytometric analysis of hemetopoietic progenitor cells in peripheral blood stem cell harvest from patients with CD34-positive acute leukemia J Immunol Methods 247 9 15 10.1016/S0022-1759(00)00315-X 1:CAS:528:DC%2BD3MXitlynsw%3D%3D 11150532 (Pubitemid 32057039)
24. N Feller GJ Ossenkoppele GWD Weijers MA van der Pol AH Westra A van Stijn, et al. 2003 High frequencies of MRD cells, normal CD34+ cells in bone marrow of AML patients are correlated with high relapse rate Leukemia 17 674 10.1038/sj.leu.2402781 (Pubitemid 36175890)
25. N Feller MA van der Pol A van Stijn GWD Weijers AH Westra BW Evertse, et al. 2004 MRD parameters using immunophenotypic detection methods are highly reliable in predicting survival in acute myeloid leukaemia Leukemia 18 1380 1390 10.1038/sj.leu.2403405 1:STN:280:DC%2BD2czms1egsQ%3D%3D 15201848 (Pubitemid 39136748)
26. E Laane AR Derolf E Bjorklund J Mazur H Everaus S Soderhall, et al. 2006 The effect of allogeneic stem cell transplantation on outcome in younger acute myeloid leukemia patients with minimal residual disease detected by flow cytometry at the end of post-remission chemotherapy Haematologica 91 833 836 16769587
27. E Bjorklund J Mazur S Soderhall A Porwit-MacDonald 2003 Flow cytometric follow-up of minimal residual disease in bone marrow gives prognostic information in children with acute lymphoblastic leukemia Leukemia 17 138 148 10.1038/sj.leu.2402736 1:STN:280:DC%2BD3s%2Fit12jsQ%3D%3D 12529671 (Pubitemid 36175899)
28. JM Bennett D Catovsky MT Daniel G Flandrin DA Galton HR Gralnick, et al. 1976 Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group Br J Haematol 33 451 458 10.1111/j.1365-2141.1976.tb03563.x 1:STN:280:DyaE2s%2FoslKisw%3D%3D 188440
29. Brunning R, Matutes E, Harris N, Flandrin G, Vardiman J, Bennett J. Acute myeloid leukemias. In: Jaffe ES, Harris NL, et al., editors. World Health organization classification of tumours. Patholoy & genetics. Tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001. p. 75-107.
30. A Schwartz RE Fernandez R Vogt JW Gratama 1996 Standardizing flow cytometry: construction of a standardized fluorescence calibration plot using matching spectral calibrators Cytometry 26 22 31 10.1002/(SICI)1097- 0320(19960315)26:1<22::AID-CYTO4>3.0.CO;2-I 1:STN:280:DyaK28vgsFegtQ%3D%3D 8809477
31. A Venditti F Buccisano G Del Poeta L Maurillo A Tamburini C Cox, et al. 2000 Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia Blood 96 3948 3952 1:CAS:528: DC%2BD3cXosVGnu74%3D 11090082
32. Altman DG. Practical statisitcs for medical research. London: Chapman & Hall; 1991. p. 403-9.
33. P Menendez MC Del Canizo A Orfao 2001 Immunophenotypic characteristics of PB-mobilised CD34+ hematopoietic progenitor cells J Biol Regul Homeost Agents 15 53 61 1:STN:280:DC%2BD3MzhsFyjtQ%3D%3D 11388745
34. M Osawa K Hanada H Hamada H Nakauchi 1996 Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell Science 273 242 245 10.1126/science.273.5272.242 1:STN:280:DyaK283nvFKnsg%3D%3D 8662508 (Pubitemid 26285891)
35. E Goussetis M Theodosaki G Paterakis J Peristeri D Petropoulos V Kitra, et al. 2000 A functional hierarchy among the CD34 + hematopoietic cells based on in vitro proliferative and differentiative potential of AC133+ CD34(bright) and AC133(dim/)-CD34+ human cord blood cells J Hematother Stem Cell Res 9 827 840 10.1089/152581600750062255 1:CAS:528:DC%2BD3MXhtFKgtbs%3D 11177594 (Pubitemid 32110281)
36. SM Vercauteren HJ Sutherland 2001 CD133 (AC133) expression on AML cells and progenitors Cytotherapy 3 449 459 10.1080/146532401317248054 1:STN:280:DC%2BD383hs12itA%3D%3D 11953029 (Pubitemid 34784642)
37. P Szabolcs MA Moore JW Young 1995 Expansion of immunostimulatory dendritic cells among the myeloid progeny of human CD34+ bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-alpha J Immunol 154 5851 5861 1:CAS:528:DyaK2MXlvVWgtLg%3D 7538534
38. LW Terstappen M Safford M Unterhalt S Konemann K Zurlutter K Piechotka, et al. 1992 Flow cytometric characterization of acute myeloid leukemia: IV. Comparison to the differentiation pathway of normal hematopoietic progenitor cells Leukemia 6 993 1000 1:STN:280:DyaK3s%2Fit1yqtQ%3D%3D 1383649
39. JJ van Dongen H Hooijkaas M Comans-Bitter K Hahlen A de Klein GE van Zanen, et al. 1985 Human bone marrow cells positive for terminal deoxynucleotidyl transferase (TdT), HLA-DR, and a T cell marker may represent prothymocytes J Immunol 135 3144 3150 2413114
40. H Long P Gaffney F Mortari JS Miller 1996 CD3 gamma, CD3 delta, and CD3 zeta mRNA in adult human marrow hematopoietic progenitors correlates with surface CD2 and CD7 expression Exp Hematol 24 1402 1408 1:CAS:528: DyaK28Xnt1aqtbo%3D 8913286
41. D Reinhardt C Langebrake U Creutzig J Vormoor C Brune M Thorwesten, et al. 2002 Minimal residual disease in acute myeloid leukemia in children-standardization and evaluation of immunophenotyping in the AML-BFM-98 study Klin Padiatr 214 179 187 10.1055/s-2002-33181 1:STN:280: DC%2BD38vhtFWruw%3D%3D 12165899 (Pubitemid 34925494)
42. JG Bender SF Williams S Myers D Nottleman WJ Lee KL Unverzagt, et al. 1992 Characterization of chemotherapy mobilized peripheral blood progenitor cells for use in autologous stem cell transplantation Bone Marrow Transplant 10 281 285 1:STN:280:DyaK3s%2FksFSisw%3D%3D 1384900
43. T Seriu S Yokota M Nakao S Misawa Y Takaue S Koizumi, et al. 1995 Prospective monitoring of minimal residual disease during the course of chemotherapy in patients with acute lymphoblastic leukemia, and detection of contaminating tumor cells in peripheral blood stem cells for autotransplantation Leukemia 9 615 623 1:STN:280:DyaK2M3ktVWgsw%3D%3D 7723394
44. FM Uckun JH Kersey R Haake D Weisdorf ME Nesbit NK Ramsay 1993 Pretransplantation burden of leukemic progenitor cells as a predictor of relapse after bone marrow transplantation for acute lymphoblastic leukemia N Engl J Med 329 1296 1301 10.1056/NEJM199310283291802 1:STN:280:DyaK2c%2FhvFGlsQ%3D%3D 8413410 (Pubitemid 23317328)
45. A Venditti F Buccisano A Tamburini G Del Poeta L Maurillo B Del Moro, et al. 1999 The amount of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia Blood 94 695A